Mr. Rodger Seccombe reports

HEALTHTAB TO POWER NHS PILOT

Avricore Health Inc.'s subsidiary HealthTab is being deployed in a new pilot launched by Barts Health NHS Trust, in collaboration with UCL Partners and the British Heart Foundation, to deliver inclisiran cholesterol-lowering injections through community pharmacies.

Key highlights:

• HealthTab enters secondary prevention care inside the NHS -- a major expansion from screening into therapy-linked workflows.
• Integration with Ortus-iHealth connects HealthTab directly into hospital clinical systems, positioning the platform as core infrastructure for NHS pharmacy-based care.
• Inclisiran pilot validates HealthTab as a trusted technology partner inside a high-profile cardiovascular program.
• Avricore significantly expands HealthTab's addressable market by enabling participation in long-term lipid management pathways.
• Inclisiran strengthens Avricore's position in the United Kingdom community pharmacy networks, aligning perfectly with NHS policy to shift chronic condition management into pharmacies.

Supported by a 198,000-pound-sterling BHF grant, the pilot reflects growing momentum toward decentralizing cardiovascular therapy delivery and reducing hospital burden by shifting appropriate services into community pharmacies, while better supporting people with long-term conditions closer to home. The initiative builds on the ELoPE-CVD program, which aims to expand access to preventive heart care in local communities and optimize lipid management for patients at highest cardiovascular risk.

HealthTab integration with Ortus health platform

A major advancement enabling this new pathway is the integration of HealthTab with the Ortus-iHealth platform, which allows pharmacy-generated results to flow directly into hospital clinical systems. This connectivity complements HealthTab's existing integration with the NHS app (through patient knows best), ensuring data are instantly available to both specialist clinicians and patients within established NHS digital pathways.

From primary to secondary prevention -- HealthTab's expanding role

HealthTab has transformed primary prevention by making early cardiometabolic testing fast, reliable and accessible in pharmacies. This pilot now brings HealthTab into secondary prevention, enabling community pharmacies to safely deliver and monitor advanced lipid-lowering therapy for patients already living with cardiovascular disease. This is a major expansion of the platform's role, placing HealthTab at the heart of pharmacy-based treatment delivery (initiation, administration and monitoring).

"Bringing inclisiran injections into community pharmacies is an important milestone for cardiovascular care, and we're proud that HealthTab is helping make it possible," said Rodger Seccombe, chief executive officer of Avricore Health. "We started by empowering pharmacies to identify risk through point-of-care testing. Now, by integrating with the Ortus platform and linking into specialist teams, HealthTab is enabling those same pharmacies to play a meaningful role in secondary prevention and long-term condition management."

HealthTab supporting pharmacy-led delivery of inclisiran

The pilot will evaluate how community pharmacies can:

• Administer inclisiran injections traditionally delivered in hospital lipid clinics;
• Initiate therapy sooner for patients awaiting specialist care;
• Identify at-risk patients through pharmacy-based cholesterol testing powered by HealthTab;
• Provide structured follow-up and monitoring as part of an integrated, long-term lipid management pathway.

The NHS has set out a clear ambition to prevent up to 150,000 heart attacks, strokes and cases of dementia over the next decade by improving detection and management of high-risk conditions, including high cholesterol. It also commits to increasing the role of community pharmacies in the management of long-term conditions and linking them more tightly into shared digital records.

A major step forward in platform expansion

Strengthens HealthTab's position inside NHS clinical pathways:

• Being deployed within a major cardiovascular program highlights HealthTab's role as a trusted platform for community-based diagnostics and workflow support, spanning both primary and secondary prevention.

Integration with Ortus enhances platform value:

• Connecting HealthTab to hospital clinical systems through Ortus moves the platform beyond diagnostics into fully integrated care team support, helping to create the kind of interoperable, shared record infrastructure envisioned in the NHS's 10-year agenda.

Supports expansion into treatment-linked workflows:

• The ability to support therapy initiation, administration and monitoring, in addition to screening and testing, expands HealthTab's relevance and value for each deployed site, and positions community pharmacies as key partners in long-term cardiovascular condition management.

HealthTab at the core of scalable, integrated POCT

HealthTab is a complete, turnkey solution for community-based POCT networks, combining best-in-class instruments, cloud software, standardized workflows, and comprehensive training and support. At its centre is a secure, cloud-based platform that seamlessly connects point-of-care analyzers, patient results and quality control data into a unified digital infrastructure for distributed testing environments.

This fully integrated approach ensures quality-assured testing, consistent data capture across all locations, and real-time analytics for public-health reporting and performance monitoring, while dramatically reducing implementation complexity for participating sites.

Commitment to quality and accuracy

HealthTab is designed to meet the highest standards of analytical performance and reliability. Through its partnership with CEQAL Inc., a world-leading reference method laboratory and member of the CDC Cholesterol Reference Method Laboratory Network, HealthTab operates a comprehensive quality management program that mirrors the rigour of accredited clinical laboratories.

The program includes centralized lot monitoring of reagents, internal quality control procedures, regular external quality assessment events and expert oversight services to support the accuracy, consistency and traceability of results to internationally recognized reference standards across participating sites.

About Avricore Health Inc.

Avricore is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. Through its flagship offering HealthTab, a wholly owned subsidiary, the company's mission is to make actionable health information more accessible to everyone by creating the world's largest network of rapid testing devices in community pharmacies.

We seek Safe Harbor.